The N-methyl-D-aspartate (NMDA) subtype of glutamate receptor plays important roles in neuronal development, plasticity, and cell death. NMDA receptor subunit 1 (NR1) is an essential subunit of the NMDA receptor and is developmentally expressed in postnatal neurons of the central nervous system. Here we identify on the NR1 promoter a binding site for myocyte enhancer factor 2C (MEF2C), a developmentally expressed neuron/muscle transcription factor found in cerebrocortical neurons, and study its regulation of the NR1 gene. Co-expression of MEF2C and Sp1 cDNAs in primary neurons or cell lines synergistically activates the NR1 promoter. Disruption of the MEF2 site or the MEF2C DNA binding domain moderately reduces this synergism. Mutation of the Sp1 sites or the activation domains of Sp1 protein strongly reduces the synergism. Results of yeast two-hybrid and co-immunoprecipitation experiments reveal a physical interaction between MEF2C and Sp1 proteins. The MEF2C DNA binding domain is sufficient for this interaction. Dominant-negative MEF2C interferes with expression of NR1 mRNA in neuronally differentiated P19 cells. Growth factors, including epidermal growth factor and basic fibroblast growth factor, can up-regulate NR1 promoter activity in stably transfected PC12 cells, even in the absence of the MEF2 site, but the Sp1 sites are necessary for this growth factor regulation, suggesting that Sp1 sites may mediate these effects.The NMDA 1 subtype of glutamate receptor plays an important role in normal brain development as well as in long term potentiation (thought to be important for some forms of learning and memory). However, in a variety of pathologic conditions, including stroke, central nervous system (CNS) trauma, and various neurodegenerative disorders, overactivation of NMDA receptors contributes to neuronal injury or death (1-3).The NMDA receptor subunit 1 (NR1) appears to be essential for NMDA receptor function, and, beginning in the early postnatal period, is abundantly expressed in almost all regions of the rodent brain. Targeted disruption of the NR1 gene in the mouse resulted in absence of functional NMDA receptors and early death of mutant mice (4 -12). Similar to many genes expressed in neurons, the NR1 transcriptional regulatory region lacks a TATA box, is GC-rich in the proximal region, and contains tandem binding sites for Sp1 (13). Sp1 is a ubiquitously expressed transcription factor capable of recruiting TFIID, thus anchoring transcriptional complexes to DNA in the absence of a TATA site (14 -17). Sp1 has been found to be important for early embryonic development in gene-targeting experiments (18). Also, our previous studies on the NR1 promoter demonstrated that the tandem Sp1 sites play an important role in the control of basal and nerve growth factor-regulated activity (19 -21).We and others recently cloned myocyte enhancer factor 2C (MEF2C), a transcription factor that is present in human brain and skeletal muscle (20,22,23). MEF2C belongs to the MEF2 subfamily of the MADS (MCM1-agamous-defic...